We are live on ! Find out more
KERX

Keryx Biopharmaceuticals Inc
KERX

Delisted

KERX was delisted on the 12th of December, 2018.

Back to rankings

132 hedge funds and large institutions have $278M invested in Keryx Biopharmaceuticals Inc in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 15

19% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 32

6% more funds holding

Funds holding: 125 → 132 (+7)

0% less call options, than puts

Call options by funds: $2.21M | Put options by funds: $2.22M

11% less capital invested

Capital invested by funds: $313M → $278M (-$35.3M)

Holders
132
Holders Change
+7
Holders Change %
+5.6%
% of All Funds
3.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
38
Reduced
32
Closed
15
Calls
$2.21M
Puts
$2.22M
Net Calls
-$6K
Net Calls Change
+$1.92M

Top Buyers

Rank Fund Capital Flow
1
PIMJS
PKO Investment Management Joint-Stock
Poland
+$7.16M
2
Morgan Stanley
Morgan Stanley
New York
+$3.76M
3
BlackRock
BlackRock
New York
+$2.6M
4
OWIM
Old West Investment Management
California
+$2.16M
5
RHJA
Rice Hall James & Associates
California
+$1.76M

Top Sellers

Rank Fund Capital Flow
1
CLM
ClearBridge LLC (Maryland)
Maryland
-$5.83M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.49M
3
State Street
State Street
Massachusetts
-$4.93M
4
Ameriprise
Ameriprise
Minnesota
-$3.95M
5
Goldman Sachs
Goldman Sachs
New York
-$3.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$653K +$47.2K +9,704 +6%
CS
27
Credit Suisse
Switzerland
$629K -$3.71K -761 -0.5%
AllianceBernstein
28
AllianceBernstein
Tennessee
$629K +$68K +13,960 +9%
BGIM
29
Brandywine Global Investment Management
Pennsylvania
$617K -$20.6K -4,240 -3%
Swiss National Bank
30
Swiss National Bank
Switzerland
$604K – – –
VEA
31
Virtus ETF Advisers
New York
$544K -$265K -54,525 -27%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$544K +$40.2K +8,260 +6%
Citadel Advisors
33
Citadel Advisors
Florida
$482K +$431K +88,501 +223%
Goldman Sachs
34
Goldman Sachs
New York
$453K -$3.52M -723,460 -86%
SG Americas Securities
35
SG Americas Securities
New York
$399K +$517K +106,091 New
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$345K +$41.6K +8,545 +10%
SRC
37
Shufro Rose & Co
New York
$345K +$92.5K +19,000 +26%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$337K – – –
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$333K +$431K +88,499 New
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$290K +$19.2K +3,935 +5%
QOP
41
Quinn Opportunity Partners
Virginia
$267K +$345K +70,900 New
WMSA
42
Weiss Multi-Strategy Advisers
New York
$255K +$28.9K +5,929 +10%
Barclays
43
Barclays
United Kingdom
$252K +$115K +23,616 +55%
UBS AM
44
UBS AM
Illinois
$247K – – –
LCC
45
Lincoln Capital Corp
Rhode Island
$247K -$10.3K -2,110 -3%
State Board of Administration of Florida Retirement System
46
State Board of Administration of Florida Retirement System
Florida
$244K – – –
UBS Group
47
UBS Group
Switzerland
$235K -$825K -169,370 -73%
AIG
48
American International Group
New York
$232K +$21.1K +4,327 +8%
ARTA
49
A.R.T. Advisors
New York
$230K +$298K +61,177 New
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$229K – – –
1
2
3 4 5

KERX Hedge Fund Activity: Q2 2018 in Review

132 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q2 2018, worth a combined $278M — down 11% from $313M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new KERX positions and 15 closed out — a net gain of 7 holders — while 38 added to existing stakes and 32 trimmed.

The largest buyer was PKO Investment Management Joint-Stock, opening a new position worth an estimated $7.16M. The largest seller was ClearBridge LLC (Maryland), cutting an estimated $5.83M.

  • 132 institutional investors held Keryx Biopharmaceuticals Inc (KERX) as of Q2 2018, up from 125 in Q1 2018.
  • Funds reported $278M of Keryx Biopharmaceuticals Inc stock for Q2 2018, down 11% quarter-over-quarter.
  • 22 funds opened new Keryx Biopharmaceuticals Inc positions in Q2 2018 and 15 closed out, a net change of +7 holders.
  • The largest Keryx Biopharmaceuticals Inc buyer in Q2 2018 was PKO Investment Management Joint-Stock, an estimated $7.16M added.
  • The largest Keryx Biopharmaceuticals Inc seller in Q2 2018 was ClearBridge LLC (Maryland), an estimated $5.83M sold.

Based on aggregated 13F filings for Q2 2018.